BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$282.26 USD
+0.46 (0.16%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $282.33 +0.07 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Brokerage Reports
Bio-Rad Laboratories, Inc. [BIO]
Reports for Purchase
Showing records 121 - 140 ( 144 total )
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
We are discontinuing coverage of Bio-Rad Laboratories
Provider: G.RESEARCH, LLC
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Terminating Coverage Due to Analyst Departure.
Provider: COLLIERS SECURITIES
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
BIO: 2Q:12 Soft Top Line and Inline Bottom Line Excl. One Time Expenses
Provider: COLLIERS SECURITIES
Analyst: HUSAIN J
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Medical Technology: Thoughts on Our Medical Technology Universe Heading Into the Dog Days of Summer
Provider: COLLIERS SECURITIES